Mapoly0001s0168 |
[GO:0000103] sulfate assimilation; [GO:0005524] ATP binding; [K00860] adenylylsulfate kinase [EC:2.7.1.25]; [PTHR11055] ADENYLSULFATE KINASE/SULFATE ADENYLTRANSFERASE; [2.7.1.25] Adenylyl-sulfate kinase.; [KOG0635] Adenosine 5'-phosphosulfate kinase; [GO:0004020] adenylylsulfate kinase activity; [PF01583] Adenylylsulphate kinase |
|
Mapoly0001s0441 |
[PTHR15664] C20ORF30 PROTEIN; [PF05915] Eukaryotic protein of unknown function (DUF872); [KOG4753] Predicted membrane protein |
|
Mapoly0003s0300 |
[KOG1515] Arylacetamide deacetylase; [GO:0016787] hydrolase activity; [GO:0008152] metabolic process; [PF07859] alpha/beta hydrolase fold; [PTHR23024] MEMBER OF 'GDXG' FAMILY OF LIPOLYTIC ENZYMES |
|
Mapoly0004s0095 |
[KOG1303] Amino acid transporters; [PF01490] Transmembrane amino acid transporter protein; [PTHR22950] AMINO ACID TRANSPORTER |
|
Mapoly0007s0039 |
[PTHR12357] YTH (YT521-B HOMOLOGY) DOMAIN-CONTAINING; [PF04146] YT521-B-like domain |
|
Mapoly0008s0153 |
[K04554] ubiquitin-conjugating enzyme E2 J2 [EC:6.3.2.19]; [PTHR24067] UBIQUITIN-CONJUGATING ENZYME E2; [GO:0016881] acid-amino acid ligase activity; [6.3.2.19] Ubiquitin--protein ligase.; [KOG0894] Ubiquitin-protein ligase; [PF00179] Ubiquitin-conjugating enzyme; [PTHR24067:SF42] UBIQUITIN-CONJUGATING ENZYME E2 J2 |
|
Mapoly0010s0119 |
[3.2.1.51] Alpha-L-fucosidase.; [PTHR10030] ALPHA-L-FUCOSIDASE; [GO:0004560] alpha-L-fucosidase activity; [K01206] alpha-L-fucosidase [EC:3.2.1.51]; [PF01120] Alpha-L-fucosidase; [GO:0005975] carbohydrate metabolic process; [KOG3340] Alpha-L-fucosidase |
|
Mapoly0012s0169 |
[PTHR22504] REPRESSOR OF RNA POLYMERASE III TRANSCRIPTION MAF1; [PTHR22504:SF0] SUBFAMILY NOT NAMED; [PF09174] Maf1 regulator; [KOG3104] Mod5 protein sorting/negative effector of RNA Pol III synthesis; [GO:0016480] negative regulation of transcription from RNA polymerase III promoter |
|
Mapoly0014s0123 |
- |
|
Mapoly0014s0215 |
[KOG0157] Cytochrome P450 CYP4/CYP19/CYP26 subfamilies; [GO:0005506] iron ion binding; [GO:0055114] oxidation-reduction process; [GO:0016705] oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; [GO:0020037] heme binding; [PF00067] Cytochrome P450; [PTHR24286] FAMILY NOT NAMED |
|
Mapoly0015s0174 |
[KOG4559] Uncharacterized conserved protein; [PF10046] Biogenesis of lysosome-related organelles complex-1 subunit 2 |
|
Mapoly0029s0029 |
[PF00923] Transaldolase; [PTHR10683] TRANSALDOLASE; [GO:0005975] carbohydrate metabolic process |
|
Mapoly0029s0033 |
[PF00923] Transaldolase; [PTHR10683] TRANSALDOLASE; [K00616] transaldolase [EC:2.2.1.2]; [GO:0005975] carbohydrate metabolic process; [2.2.1.2] Transaldolase. |
|
Mapoly0034s0036 |
[PTHR22766] RING FINGER PROTEIN 24-RELATED; [GO:0005515] protein binding; [PF13639] Ring finger domain; [GO:0008270] zinc ion binding; [PTHR22766:SF29] SUBFAMILY NOT NAMED |
|
Mapoly0055s0111 |
- |
|
Mapoly0075s0085 |
- |
|
Mapoly0090s0082 |
[PF00026] Eukaryotic aspartyl protease; [K08245] phytepsin [EC:3.4.23.40]; [PF05184] Saposin-like type B, region 1; [3.4.23.40] Phytepsin.; [PTHR13683] ASPARTYL PROTEASES; [PF03489] Saposin-like type B, region 2; [GO:0004190] aspartic-type endopeptidase activity; [GO:0006508] proteolysis; [GO:0006629] lipid metabolic process |
|
Mapoly0122s0009 |
[KOG1542] Cysteine proteinase Cathepsin F; [GO:0008234] cysteine-type peptidase activity; [PF08246] Cathepsin propeptide inhibitor domain (I29); [PF00112] Papain family cysteine protease; [PTHR12411] CYSTEINE PROTEASE FAMILY C1-RELATED; [GO:0006508] proteolysis |
|
Mapoly0140s0025 |
[GO:0004356] glutamate-ammonia ligase activity; [GO:0006542] glutamine biosynthetic process; [GO:0006807] nitrogen compound metabolic process; [PTHR20852] GLUTAMINE SYNTHETASE; [PF03951] Glutamine synthetase, beta-Grasp domain; [PF00120] Glutamine synthetase, catalytic domain |
|
Mapoly0146s0004 |
[KOG1577] Aldo/keto reductase family proteins; [PTHR11732] ALDO/KETO REDUCTASE; [PF00248] Aldo/keto reductase family |
|
Mapoly0191s0006 |
[KOG0143] Iron/ascorbate family oxidoreductases; [GO:0055114] oxidation-reduction process; [PF14226] non-haem dioxygenase in morphine synthesis N-terminal; [GO:0016706] oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors; [PTHR10209] OXIDOREDUCTASE, 2OG-FE(II) OXYGENASE FAMILY PROTEIN; [GO:0016491] oxidoreductase activity; [K06892] ATP-dependent Clp protease adaptor protein ClpS; [PF03171] 2OG-Fe(II) oxygenase superfamily |
|